| Date Filed | Type | Description |
| 03/14/2023 |
4
| Gelder Mark S. MD (CHIEF MEDICAL OFFICER) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 62,000 options to buy
@ $0.73, valued at
$45.3k
Granted 20,667 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Gelder Mark S. MD (CHIEF MEDICAL OFFICER) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,242 shares
@ $1.36, valued at
$1.7k
Exercised 5,833 restricted stock units
@ $0 |
|
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Gelder Mark S. MD (Chief Medical Officer) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 41,825 options to buy
@ $5.19, valued at
$217.1k
Granted 13,950 restricted stock units
@ $0 |
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/15/2014 |
4
| Gelder Mark S. MD (SVP & Chief Medical Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 45,000 options to buy
@ $9.05, valued at
$407.3k
|
|
| 03/28/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/07/2014 |
4
| Gelder Mark S. MD (SVP & Chief Medical Officer) has filed a Form 4 on AP PHARMA INC /DE/|
Txns:
| Granted 1,600,000 options to buy
@ $0.45, valued at
$720k
|
|
| 05/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/12/2013 |
4
| Gelder Mark S. MD (SVP & Chief Medical Officer) has filed a Form 4 on AP PHARMA INC /DE/|
Txns:
| Granted 75,000 options to buy
@ $0.75, valued at
$56.3k
|
|